Approvals/TGA/SIGNIFOR LAR pasireotide 40 mg (as embonate) modified release powder for injection vial and 2 mL diluent in prefilled syringe composite pack

Approved

STANDARD

SIGNIFOR LAR pasireotide 40 mg (as embonate) modified release powder for injection vial and 2 mL diluent in prefilled syringe composite pack

Recordati Rare Diseases Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: Dec 9, 2025
Approval ID: a1496aaab4edf04d
Company: Recordati Rare Diseases Australia Pty Ltd
Type: Standard

Approval Details

Approval Id: a1496aaab4edf04d
Product Name: SIGNIFOR LAR pasireotide 40 mg (as embonate) modified release powder for injection vial and 2 mL diluent in prefilled syringe composite pack
Artg Id: 225273
Artg Name: SIGNIFOR LAR pasireotide 40 mg (as embonate) modified release powder for injection vial and 2 mL diluent in prefilled syringe composite pack
Sponsor: Recordati Rare Diseases Australia Pty Ltd
Company Detail Path: /organization/recordati-rare-diseases-australia-pty-ltd
Artg Date: 2015-05-04
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/a6655d24f8cc0043aae915eda04af481.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/281956df96a097ee2b42f62825f37002.pdf

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

a1496aaab4edf04d

Type

Standard

Back to TGA Approvals